The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
The Wnt antagonist secreted frizzled‐related protein‐1 controls osteoblast and osteocyte apoptosis
Open accessAbstract
Mechanisms controlling human bone formation remain to be fully elucidated. We have used differential display‐polymerase chain reaction analysis to characterize osteogenic pathways in conditionally immortalized human osteoblasts (HOBs) representing distinct stages of differentiation. We identified 82 differentially expressed messages and found that the Wnt antagonist secreted frizzled‐related protein (sFRP)‐1 was the most highly regulated of these. Transient transfection of HOBs with sFRP‐1 suppressed canonical Wnt signaling by 70% confirming its antagonistic function in these cells. Basal sFRP‐1 mRNA levels increased 24‐fold during HOB differentiation from pre‐osteoblasts to pre‐osteocytes, and then declined in mature osteocytes. This expression pattern correlated with levels of cellular viability such that the pre‐osteocytes, which had the highest levels of sFRP‐1 mRNA, also had the highest rate of cell death. Basal sFRP‐1 mRNA levels also increased 29‐fold when primary human mesenchymal stem cells were differentiated to osteoblasts supporting the developmental regulation of the gene. Expression of sFRP‐1 mRNA was induced 38‐fold following prostaglandin E 2 (PGE 2) treatment of pre‐osteoblasts and mature osteoblasts that had low basal message levels. In contrast, sFRP‐1 expression was down‐regulated by as much as 80% following transforming growth factor (TGF)‐β1 treatment of pre‐osteocytes that had high basal mRNA levels. Consistent with this, treatment of pre‐osteoblasts and mature osteoblasts with PGE 2 increased apoptosis threefold, while treatment of pre‐osteocytes with TGF‐β1 decreased cell death by 50%. Likewise, over‐expression of sFRP‐1 in HOBs accelerated the rate of cell death threefold. These results establish sFRP‐1 as an important negative regulator of human osteoblast and osteocyte survival. © 2005 Wiley‐Liss, Inc.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
WNT and β-catenin signalling: diseases and therapies
Moon, R. T., Kohn, A. D., Ferrari, G. V. D., & Kaykas, A. (2004) · Nature Reviews Genetics · doi:10.1038/nrg1427 · Cited by 1,763
Secreted antagonists of the Wnt signalling pathway
Kawano, Y., & Kypta, R. (2003) · Journal of Cell Science · doi:10.1242/jcs.00623 · Cited by 1,584
Cited by
Pathogenesis of osteoporosis: concepts, conflicts, and prospects
Raisz, L. G. (2005) · Journal of Clinical Investigation · doi:10.1172/jci27071 · Cited by 1,779
Regulation of bone mass by Wnt signaling
Krishnan, V. (2006) · Journal of Clinical Investigation · doi:10.1172/jci28551 · Cited by 1,407
The Osteocyte: An Endocrine Cell … and More
Dallas, S. L., Prideaux, M., & Bonewald, L. F. (2013) · Endocrine Reviews · doi:10.1210/er.2012-1026 · Cited by 1,042
Lin, C., Jiang, X., Dai, Z., Guo, X., Weng, T., Wang, J., Li, Y., Feng, G., Gao, X., & He, L. (2009) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.090411 · Cited by 628
The cell biology of bone metabolism
Datta, H. K., Ng, W. F., Walker, J. A., Tuck, S. P., & Varanasi, S. S. (2008) · Journal of Clinical Pathology · doi:10.1136/jcp.2007.048868 · Cited by 614
Tyagi, A. M., Yu, M., Darby, T. M., Vaccaro, C., Li, J.-Y., Owens, J. A., Hsu, E., Adams, J., Weitzmann, M. N., Jones, R. M., et al. (2018) · Immunity · doi:10.1016/j.immuni.2018.10.013 · Cited by 564
Pederson, L., Ruan, M., Westendorf, J. J., Khosla, S., & Oursler, M. J. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0805133106 · Cited by 556
The roles of signaling pathways in bone repair and regeneration
Majidinia, M., Sadeghpour, A., & Yousefi, B. (2018) · Journal of Cellular Physiology · doi:10.1002/jcp.26042 · Cited by 513
Networks and hubs for the transcriptional control of osteoblastogenesis
Lian, J. B., Stein, G. S., Javed, A., van Wijnen, A. J., Stein, J. L., Montecino, M., Hassan, M. Q., Gaur, T., Lengner, C. J., & Young, D. W. (2006) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-006-9001-5 · Cited by 468
Self-citationThe gut-bone axis: How bacterial metabolites bridge the distance
Zaiss, M. M., Jones, R. M., Schett, G., & Pacifici, R. (2019) · Journal of Clinical Investigation · doi:10.1172/jci128521 · Cited by 403
Update on Wnt signaling in bone cell biology and bone disease
Monroe, D. G., McGee-Lawrence, M. E., Oursler, M. J., & Westendorf, J. J. (2012) · Gene · doi:10.1016/j.gene.2011.10.044 · Cited by 392
Building bone to reverse osteoporosis and repair fractures
Khosla, S., Westendorf, J. J., & Oursler, M. J. (2008) · Journal of Clinical Investigation · doi:10.1172/jci33612 · Cited by 353
Mechanisms of bone repair and regeneration
Deschaseaux, F., Sensébé, L., & Heymann, D. (2009) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2009.07.002 · Cited by 324
Wnt signaling and osteoblastogenesis
Bodine, P. V. N., & Komm, B. S. (2007) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-006-9002-4 · Cited by 285
Self-citationActivating Wnt/β-catenin signaling pathway for disease therapy: Challenges and opportunities
Huang, P., Yan, R., Zhang, X., Wang, L., Ke, X., & Qu, Y. (2019) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2018.11.008 · Cited by 268
Zhu, M., Chen, M., Zuscik, M., Wu, Q., Wang, Y., Rosier, R. N., O'Keefe, R. J., & Chen, D. (2008) · Arthritis & Rheumatism · doi:10.1002/art.23614 · Cited by 254
Osteoblasts in osteoporosis: Past, emerging, and future anabolic targets
Marie, P. J., & Kassem, M. (2011) · European Journal of Endocrinology · doi:10.1530/eje-11-0132 · Cited by 234
Osteocytic signalling pathways as therapeutic targets for bone fragility
Plotkin, L. I., & Bellido, T. (2016) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2016.71 · Cited by 206
Treiber, N., Maity, P., Singh, K., Kohn, M., Keist, A. F., Ferchiu, F., Sante, L., Frese, S., Bloch, W., Kreppel, F., et al. (2011) · Aging Cell · doi:10.1111/j.1474-9726.2010.00658.x · Cited by 109
Gut-microbiota derived bioactive metabolites and their functions in host physiology
Debnath, N., Kumar, R., Kumar, A., Mehta, P. K., & Yadav, A. K. (2021) · Biotechnology and Genetic Engineering Reviews · doi:10.1080/02648725.2021.1989847 · Cited by 77
Metadata
- Authors
- Bodine, P. V. N., Billiard, J., Moran, R. A., Ponce‐de‐Leon, H., McLarney, S., Mangine, A., Scrimo, M. J., Bhat, R. A., Stauffer, B., Green, J., Stein, G. S., Lian, J. B., & Komm, B. S.
- Venue
- Journal of Cellular Biochemistry
- Publisher
- Wiley
- Published
- 2005-09-07
- Volume
- 96
- Issue
- 6
- Pages
- 1212-1230
- ISSN
- 0730-2312 (ISSN-L)
- 1097-4644
- OpenAlex
- W1984199402
- Cited by
- 166
- References
- 2
- FWCI
- 5.42
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.